ℹ️
🇬🇧
Search
Search for publications relevant for "statin intolerance"
statin intolerance
Publication
Class
Person
Publication
Programmes
Export current view
publication
Statin Intolerance in Clinical Practice
2020 |
First Faculty of Medicine
publication
A practical approach to statin intolerance
2015 |
First Faculty of Medicine
publication
Statin Intolerance: the Clinician's Perspective
2015 |
First Faculty of Medicine
publication
Statin intolerance - finding practical solutions
2017 |
First Faculty of Medicine
publication
The Role of Nutraceuticals in Statin Intolerant Patients
2018 |
First Faculty of Medicine
publication
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel
+1
2015 |
First Faculty of Medicine
publication
Indication of lipid-lowering therapy in a „statin-intolerant“ patient
2009 |
First Faculty of Medicine
publication
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance The GAUSS-3 Randomized Clinical Trial
2016 |
First Faculty of Medicine
publication
Food supplements in dyslipidemia therapy - ArmoLIPID PLU
2017 |
First Faculty of Medicine
publication
PCSK9 inhibition as the new hope for patients with familial hypercholesterolemia, statin intolerance and eventually for those at the highest cardiovascular risk? Focused on alirocumab, Praluent(R)
2015 |
First Faculty of Medicine
publication
Statins and myopathy
2013 |
Faculty of Medicine in Pilsen
publication
IMPROVE-IT Study - Commentary
2015 |
Faculty of Medicine in Pilsen
publication
Alirocumab, Praluent(R) in the light of studies
2016 |
First Faculty of Medicine
publication
Statin therapy in athletes and patients performing regular intense exercise-Position paper from the International Lipid Expert Panel (ILEP)
Publication without faculty affiliation
publication
ScreenPro FH: From the Czech MedPed to International Collaboration. ScreenPro FH Is a Participating Project of the EAS-FHCS
2017 |
First Faculty of Medicine
publication
Why do we fail when treating dyslipidemia?
+1
2018 |
First Faculty of Medicine
publication
The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion
2019 |
First Faculty of Medicine
publication
Statin-associated myopathy: clinical guideline of Slovak Atherosclerosis Association and Czech Society for Atherosclerosis
2016 |
First Faculty of Medicine, Central Library of Charles University
publication
PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated? Czech atherosclerosis society statement
2016 |
First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Alirocumab in treatment of combined dyslipidemia
2020 |
Third Faculty of Medicine
publication
Ezetimibe in the treatment of diabetic dyslipidemia
2018 |
First Faculty of Medicine
publication
PCSK9 inhibitors in light of recent data
2016 |
First Faculty of Medicine
publication
Monoklonal PCSK9 antibodies in the treatment of dyslipidemias
2014 |
First Faculty of Medicine
publication
Evolocumab - antibody against PCSK9 with a profound lipid-lowering effect
2015 |
First Faculty of Medicine
publication
Bempedoic acid in the context of current hypolipidemic treatment options and the results of the CLEAR OUTCOMES trial
2023 |
First Faculty of Medicine
publication
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
2017 |
First Faculty of Medicine
publication
Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
2017 |
First Faculty of Medicine
publication
Six questions about the use of ezetimibe in the year 2018
2018 |
First Faculty of Medicine